The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert warning Nigerians about the illegal distribution and sale of substandard and falsified Knowit Insulin Syringe 40 IU 29g X 1/2. The alert, tagged *Public Alert No. 02/2025*, was shared via the agency’s official X handle (@NafdacAgency) earlier today.
According to the statement, the Association of Community Pharmacists of Nigeria (ACPN) raised concerns about the continued use of 40 IU/ML insulin syringes in the country, despite the availability of 100 IU/ML syringes. The 40 IU/ML syringes were previously approved for administering Lente animal insulins, which were available in both 40 IU/ML and 100 IU/ML strengths. However, with the discontinuation of animal insulins and the introduction of human insulins standardized to 100 IU/ML, the 40 IU/ML syringes are no longer applicable and have not been registered by NAFDAC since 2019.
NAFDAC emphasized that the use of these outdated syringes could lead to dosing errors, posing serious health risks to diabetic patients. The agency also revealed that the product’s NAFDAC registration number (03-2933) is falsified, as the license expired in 2019.
**Product Details:**
– **Brand Name:** Knowit Insulin Syringe
– **Generic Name:** Insulin Syringe 40IU 29G x 1/2
– **Batch Number:** N/A
– **Manufacturing Date:** August 2020
– **Expiry Date:** August 2025
– **Manufacturer:** Unknown
– **Distributor:** Chivic Limited
NAFDAC has urged healthcare professionals and consumers to be vigilant and report any suspected sale or distribution of the product. The agency provided the following contact information for reporting:
– **Phone:** 0800-162-3322
– **Email:** [email protected]
This alert comes as part of NAFDAC’s ongoing efforts to curb the circulation of substandard and falsified medical products in Nigeria, safeguarding public health and ensuring the safety of medications.
For further updates, follow NAFDAC on X at @NafdacAgency or visit their official website.
*By [Your Name], Online News Reporter*
